Athanasios Tsiatis
Directeur Technique/Scientifique/R&D chez ALX ONCOLOGY HOLDINGS INC.
Profil
Athanasios Tsiatis is currently the Senior Vice President-Clinical Development at ALX Oncology Holdings, Inc. Prior to this, he was the Vice President-Clinical Development at Plexxikon, Inc. from 2018 to 2021.
He completed his undergraduate degree at New York University and obtained his doctorate from Vanderbilt University School of Medicine.
Postes actifs de Athanasios Tsiatis
| Sociétés | Poste | Début |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Directeur Technique/Scientifique/R&D | 01/11/2021 |
Anciens postes connus de Athanasios Tsiatis
| Sociétés | Poste | Fin |
|---|---|---|
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Directeur Technique/Scientifique/R&D | 01/11/2021 |
Formation de Athanasios Tsiatis
| New York University | Undergraduate Degree |
| Vanderbilt University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Commercial Services |
